Cancer risks following diagnostic and therapeutic radiation exposure in children.

Cancer risks following diagnostic and therapeutic radiation exposure in children. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cancer risks following diagnostic and therapeutic radiation exposure in children. Abstract Text:

Ruth A Kleinerman,

The growing use of interventional and fluoroscopic imaging in children represents a tremendous benefit for the diagnosis and treatment of benign conditions. Along with the increasing use and complexity of these procedures comes concern about the cancer risk associated with ionizing radiation exposure to children. Children are considerably more sensitive to the carcinogenic effects of ionizing radiation than adults, and children have a longer life expectancy in which to express risk. Numerous epidemiologic cohort studies of childhood exposure to radiation for treatment of benign diseases have demonstrated radiation-related risks of cancer of the thyroid, breast, brain and skin, as well as leukemia. Many fewer studies have evaluated cancer risk following diagnostic radiation exposure in children. Although radiation dose for a single procedure might be low, pediatric patients often receive repeated examinations over time to evaluate their conditions, which could result in relatively high cumulative doses. Several cohort studies of girls and young women subjected to multiple diagnostic radiation exposures have been informative about increased mortality from breast cancer with increasing radiation dose, and case-control studies of childhood leukemia and postnatal diagnostic radiation exposure have suggested increased risks with an increasing number of examinations. Only two long-term follow-up studies of cancer following cardiac catheterization in childhood have been conducted, and neither reported an overall increased risk of cancer. Most cancers can be induced by radiation, and a linear dose-response has been noted for most solid cancers. Risks of radiation-related cancer are greatest for those exposed early in life, and these risks appear to persist throughout life.

Cancer risks following diagnostic and therapeutic radiation exposure in children. Publishing Authors By Initials

RA Kleinerman,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Cancer risks following diagnostic and therapeutic radiation exposure in children. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Pediatric radiology

VOLUME: 36 Suppl 14

Page Numbers: 121-5

Journal Abbreviation:

ISSN: 0301-0449

DAY: 9

MONTH: Sep

YEAR: 2006

Cancer risks following diagnostic and therapeutic radiation exposure in children. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 365332

Cancer risks following diagnostic and therapeutic radiation exposure in children. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Cancer risks following diagnostic and therapeutic radiation exposure in children. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Cancer risks following diagnostic and therapeutic radiation exposure in children.

AFFILIATION: Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, EPS 7044, 6120 Executive Blvd., Rockville, MD, 20852, USA, kleinerr@mail.nih.gov.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pediatr Radiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cancer risks following diagnostic and therapeutic radiation exposure in children Related Publications

• Bone Marrow Subsets Differentiate into Endothelial Cells and Pericytes Contributing to Ewing's Tumor Vessels.
• Cancer risks following diagnostic and therapeutic radiation exposure in children.
• Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers.
• Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.
• Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
• Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis.
• Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma.
• Paraquat in the rabbit.
• Pathogenesis of so-called diffuse vascular or collagen disease.
• Some aspects of pulmonary pathology in the Syrian hamster.
• Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.
• Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
• Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.
• The Osterix Transcription Factor Down-Regulates Interleukin-1{alpha} Expression in Mouse Osteosarcoma Cells.
• VEGF(165) expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature.
• VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells.
• VEGF165, but not VEGF189, Stimulates Vasculogenesis and Bone Marrow Cell Migration into Ewing's Sarcoma Tumors In vivo.